Research & Innovation Related Content

The ATTRACT Consortium uses public funding to lower the intrinsic risk that breakthrough technology bears as it progresses.

Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.

Indro Mukerjee has been appointed the new CEO of Innovate UK, the UK’s innovation agency.

James Chen, a philanthropist, discusses how philanthropists can follow the governments lead on addressing moonshot issues.

Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.

In the April 2021 edition of Asia Analysis, Maiko Shimmura, from the New Energy and Industrial Technology Development Organization, speaks about Japan’s efforts toward increasing the use of hydrogen energy.

Here, we learn how world leading supplier Bioquell devised a PRP for a Biopharmaceutical Production Facility ensuring high-level bio-decontamination in the event of contamination.

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.

The April 2021 edition of Open Access Government speaks about government policy issues globally, like COVID-19, health & social care, research & innovation, finance, digital transformation, agriculture, environment and energy.

Gwo-shyh Song, Associate Professor at the National Taiwan University and Global Aqua Survey Ltd, walks us through his high-resolution seabed geophysical survey research around offshore areas in Taiwan.

From 2022, Horizon Europe funding applications by public bodies, research organisations and higher education institutions will only be considered if they have a gender equality plan.

The 'London patient' joins the 'Berlin patient' as the second person in history to be cured of HIV, which is achieved via transplant of rare HIV-resistant stem cells.

Scientists at the University of Pittsburgh are creating COVID-19 antibodies in llamas, to understand how humans could engineer better immune responses.

Luis García-Tabarés from CIEMAT, as Technical Manager in the H2020-funded SEA-TITAN, tells us what we need to know about the first of a kind superconducting direct drive power take off.

Here, we learn about the many uses of spirulina algae, and how BBI JU funded project SpiralG is assessing the sustainability and profitability of each spirulina biomass component.

An international research team have discovered that the genetics of eating disorders and some psychiatric disorders have some similarities, raising new questions about treatment for both.

Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.

New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.

The first Horizon Europe grants will be launched today (25 February), with Starting Grants for researchers worth €619 million available.

People living with HIV can now get a COVID vaccine without having to tell the doctor their status - right now, the stigma is holding some back from coming forward to get their vaccination.